BioLineRx
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioLineRx and other ETFs, options, and stocks.About BLRX
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. Its product pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is an immunotherapy treatment used for multiple solid tumors.
CEOPhilip Adam Serlin
CEOPhilip Adam Serlin
Employees28
Employees28
HeadquartersModi'in, HaMerkaz
HeadquartersModi'in, HaMerkaz
Founded2003
Founded2003
Employees28
Employees28
BLRX Key Statistics
Market cap19.52M
Market cap19.52M
Price-Earnings ratio-1.66
Price-Earnings ratio-1.66
Dividend yield—
Dividend yield—
Average volume65.55K
Average volume65.55K
High today$4.63
High today$4.63
Low today$4.46
Low today$4.46
Open price$4.60
Open price$4.60
Volume18.66K
Volume18.66K
52 Week high$35.60
52 Week high$35.60
52 Week low$2.30
52 Week low$2.30
BLRX News
TipRanks 3d
BioLineRx Ltd. Approves Key Proposals at Annual MeetingDon’t Miss TipRanks’ Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights...